# FDA Inspection 1117006 - Xellia Pharmaceuticals USA LLC - January 31, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/xellia-pharmaceuticals-usa-llc/23fcae5b-8d28-45e0-b742-7d813529b981/
Source feed: FDA_Inspections

> FDA Inspection 1117006 for Xellia Pharmaceuticals USA LLC on January 31, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117006
- Company Name: Xellia Pharmaceuticals USA LLC
- Inspection Date: 2020-01-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220071 - 2023-09-29](https://www.globalkeysolutions.net/api/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8d9b38c-a723-4609-9dd4-0b9f92e5c364/)
- [FDA Inspection 1194565 - 2022-12-15](https://www.globalkeysolutions.net/api/records/fda_inspections/xellia-pharmaceuticals-usa-llc/cca7b29f-9faa-43de-9401-03124cde0897/)
- [FDA Inspection 1161837 - 2022-02-07](https://www.globalkeysolutions.net/api/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d429f017-a9d2-407b-a75e-05a5eb33faa5/)
- [FDA Inspection 990058 - 2016-10-13](https://www.globalkeysolutions.net/api/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8709417-c6c0-4b50-9435-3d7c749a5d34/)

Company: https://www.globalkeysolutions.net/companies/xellia-pharmaceuticals-usa-llc/a3a2eda2-040c-4cb8-8df0-2dd3fb12332f

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c